Response to: Correspondence on ‘Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer-a real-world, retrospective bicenter cohort study’ by Wang

Saved in:
Bibliographic Details
Main Authors: Egbert F Smit, Willemijn S M E Theelen, Michiel M Smeenk, Vincent van der Noort, Hanieh Abedian Kalkhoran, Jeroen J M A Hendrikx
Format: Article
Language:English
Published: BMJ Publishing Group 2025-07-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/13/7/e012594.full
Tags: Add Tag
No Tags, Be the first to tag this record!